These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9802973)

  • 1. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum.
    Smyth MJ; Kelly JM; Baxter AG; Körner H; Sedgwick JD
    J Exp Med; 1998 Nov; 188(9):1611-9. PubMed ID: 9802973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
    Taylor MA; Ward B; Schatzle JD; Bennett M
    Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells.
    Screpanti V; Wallin RP; Ljunggren HG; Grandien A
    J Immunol; 2001 Aug; 167(4):2068-73. PubMed ID: 11489989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
    Austin Taylor M; Bennett M; Kumar V; Schatzle JD
    J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing.
    Komatsu M; Mammolenti M; Jones M; Jurecic R; Sayers TJ; Levy RB
    Blood; 2003 May; 101(10):3991-9. PubMed ID: 12521999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection.
    Cretney E; Degli-Esposti MA; Densley EH; Farrell HE; Davis-Poynter NJ; Smyth MJ
    J Exp Med; 1999 Aug; 190(3):435-44. PubMed ID: 10430631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
    Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
    J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells.
    Street SE; Hayakawa Y; Zhan Y; Lew AM; MacGregor D; Jamieson AM; Diefenbach A; Yagita H; Godfrey DI; Smyth MJ
    J Exp Med; 2004 Mar; 199(6):879-84. PubMed ID: 15007091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perforin dependence of natural killer cell-mediated tumor control in vivo.
    van den Broek MF; Kägi D; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 Dec; 25(12):3514-6. PubMed ID: 8566046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perforin is a major contributor to NK cell control of tumor metastasis.
    Smyth MJ; Thia KY; Cretney E; Kelly JM; Snook MB; Forbes CA; Scalzo AA
    J Immunol; 1999 Jun; 162(11):6658-62. PubMed ID: 10352283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of quantitative trait loci determining NK cell-mediated resistance to MHC class I-deficient bone marrow grafts in perforin-deficient mice.
    Johansson MH; Taylor MA; Jagodic M; Tus K; Schatzle JD; Wakeland EK; Bennett M
    J Immunol; 2006 Dec; 177(11):7923-9. PubMed ID: 17114464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of perforin-independent NK cell-mediated cytotoxicity.
    Wallin RP; Screpanti V; Michaëlsson J; Grandien A; Ljunggren HG
    Eur J Immunol; 2003 Oct; 33(10):2727-35. PubMed ID: 14515256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased tumor surveillance in perforin-deficient mice.
    van den Broek ME; Kägi D; Ossendorp F; Toes R; Vamvakas S; Lutz WK; Melief CJ; Zinkernagel RM; Hengartner H
    J Exp Med; 1996 Nov; 184(5):1781-90. PubMed ID: 8920866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
    Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.
    Tajima A; Tanaka T; Ebata T; Takeda K; Kawasaki A; Kelly JM; Darcy PK; Vance RE; Raulet DH; Kinoshita K; Okumura K; Smyth MJ; Yagita H
    J Immunol; 2003 Aug; 171(4):1715-21. PubMed ID: 12902470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control.
    Pardo J; Balkow S; Anel A; Simon MM
    Eur J Immunol; 2002 Oct; 32(10):2881-7. PubMed ID: 12355441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells promote peritoneal xenograft rejection through an IFN-gamma-dependent mechanism.
    Lin ML; Zhan Y; Nutt SL; Brady J; Wojtasiak M; Brooks AG; Lew AM
    Xenotransplantation; 2006 Nov; 13(6):536-46. PubMed ID: 17059581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo.
    Kelly JM; Takeda K; Darcy PK; Yagita H; Smyth MJ
    J Immunol; 2002 May; 168(9):4472-9. PubMed ID: 11970991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection.
    Kelly JM; Darcy PK; Markby JL; Godfrey DI; Takeda K; Yagita H; Smyth MJ
    Nat Immunol; 2002 Jan; 3(1):83-90. PubMed ID: 11743585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perforin-dependent cytolytic responses in beta2-microglobulin-deficient mice.
    Smyth MJ; Snook MB
    Cell Immunol; 1999 Aug; 196(1):51-9. PubMed ID: 10486155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.